| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $209.9M | +8.1% | +79.5% |
| SG&A Expense | $32.4M | +1.3% | +41.1% |
| Operating Income | -$242.4M | -7.1% | -73.2% |
| Income Tax | $0 | — | — |
| Net Income | -$212.8M | -27.8% | -106.4% |
| EPS (Basic) | -$1.56 | -27.9% | -88.0% |
| EPS (Diluted) | -$1.56 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $281.1M | -8.4% | -73.2% |
| Short-term Investments | $1.43B | +5.6% | +26.5% |
| Current Assets | $1.77B | +3.0% | -20.2% |
| Total Assets | $3.17B | -4.0% | -10.9% |
| Current Liabilities | $200.0M | +29.5% | +61.6% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$430.7M | — | — |
| Capital Expenditures | $11.1M | — | — |
| Investing Cash Flow | $322.2M | — | — |
| Financing Cash Flow | -$394K | — | — |
| Free Cash Flow | -$441.8M | — | — |
| -88.0% |
| $278.7M |
| +19.1% |
| +96.1% |
| Stockholders' Equity | $2.89B | -5.8% | -15.4% |